Return On Assets in % of Whitehawk Therapeutics, Inc. from Q1 2014 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Whitehawk Therapeutics, Inc. quarterly and annual Return On Assets history and change rate from Q1 2014 to Q3 2025.
  • Whitehawk Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -9.6%, a 83% increase year-over-year.
  • Whitehawk Therapeutics, Inc. annual Return On Assets for 2024 was -69%, a 56% decline from 2023.
  • Whitehawk Therapeutics, Inc. annual Return On Assets for 2023 was -44%, a 19% decline from 2022.
  • Whitehawk Therapeutics, Inc. annual Return On Assets for 2022 was -37%, a 66% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Whitehawk Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -9.6% +48% +83% 01 Jul 2025 30 Sep 2025
Q2 2025 -7.3% +47% +86% 01 Apr 2025 30 Jun 2025
Q1 2025 22% +74% 01 Jan 2025 31 Mar 2025
Q4 2024 -69% -25% -56% 01 Oct 2024 31 Dec 2024
Q3 2024 -57% -18% -46% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% -19% -53% 01 Apr 2024 30 Jun 2024
Q1 2024 -52% -15% -41% 01 Jan 2024 31 Mar 2024
Q4 2023 -44% -7% -19% 01 Oct 2023 31 Dec 2023
Q3 2023 -39% +0.91% +2.3% 01 Jul 2023 30 Sep 2023
Q2 2023 -35% +55% +61% 01 Apr 2023 30 Jun 2023
Q1 2023 -37% +57% +61% 01 Jan 2023 31 Mar 2023
Q4 2022 -37% +71% +66% 01 Oct 2022 31 Dec 2022
Q3 2022 -40% +89% +69% 01 Jul 2022 30 Sep 2022
Q2 2022 -90% -85% -1668% 01 Apr 2022 30 Jun 2022
Q1 2022 -94% -79% -546% 01 Jan 2022 31 Mar 2022
Q4 2021 -109% -99% -1072% 01 Oct 2021 31 Dec 2021
Q3 2021 -129% -92% -247% 01 Jul 2021 30 Sep 2021
Q2 2021 -5.1% +37% +88% 01 Apr 2021 30 Jun 2021
Q1 2021 -14% +28% +66% 01 Jan 2021 31 Mar 2021
Q4 2020 -9.3% +40% +81% 01 Oct 2020 31 Dec 2020
Q3 2020 -37% +14% +27% 01 Jul 2020 30 Sep 2020
Q2 2020 -42% -24% -127% 01 Apr 2020 30 Jun 2020
Q1 2020 -42% -25% -139% 01 Jan 2020 31 Mar 2020
Q4 2019 -49% -30% -157% 01 Oct 2019 31 Dec 2019
Q3 2019 -51% -33% -176% 01 Jul 2019 30 Sep 2019
Q2 2019 -19% +55% +75% 01 Apr 2019 30 Jun 2019
Q1 2019 -18% +86% +83% 01 Jan 2019 31 Mar 2019
Q4 2018 -19% +57% +75% 01 Oct 2018 31 Dec 2018
Q3 2018 -18% +61% +77% 01 Jul 2018 30 Sep 2018
Q2 2018 -74% +36% +33% 01 Apr 2018 30 Jun 2018
Q1 2018 -104% +80% +43% 01 Jan 2018 31 Mar 2018
Q4 2017 -76% +2711% +97% 01 Oct 2017 31 Dec 2017
Q3 2017 -79% +89959% +100% 01 Jul 2017 30 Sep 2017
Q2 2017 -111% +58876% +100% 01 Apr 2017 30 Jun 2017
Q1 2017 -184% +34896% +99% 01 Jan 2017 31 Mar 2017
Q4 2016 -2786% -2570% -1189% 01 Oct 2016 31 Dec 2016
Q3 2016 -90038% -89760% 01 Jul 2016 30 Sep 2016
Q2 2016 -58986% -58766% 01 Apr 2016 30 Jun 2016
Q1 2016 -35079% -34837% 01 Jan 2016 31 Mar 2016
Q4 2015 -216% +144% +40% 01 Oct 2015 31 Dec 2015
Q3 2015 -278%* +28% 01 Jul 2015 30 Sep 2015
Q2 2015 -221%* +111% 01 Apr 2015 30 Jun 2015
Q1 2015 -242%* -7.2% 01 Jan 2015 31 Mar 2015
Q4 2014 -360% 01 Oct 2014 31 Dec 2014
Q3 2014 -306%* 01 Jul 2014 30 Sep 2014
Q2 2014 -331%* 01 Apr 2014 30 Jun 2014
Q1 2014 -235%* 01 Jan 2014 31 Mar 2014

Whitehawk Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -69% -25% -56% 01 Jan 2024 31 Dec 2024
2023 -44% -7% -19% 01 Jan 2023 31 Dec 2023
2022 -37% +71% +66% 01 Jan 2022 31 Dec 2022
2021 -109% -99% -1072% 01 Jan 2021 31 Dec 2021
2020 -9.3% +40% +81% 01 Jan 2020 31 Dec 2020
2019 -49% -30% -157% 01 Jan 2019 31 Dec 2019
2018 -19% +57% +75% 01 Jan 2018 31 Dec 2018
2017 -76% +2711% +97% 01 Jan 2017 31 Dec 2017
2016 -2786% -2570% -1189% 01 Jan 2016 31 Dec 2016
2015 -216% +144% +40% 01 Jan 2015 31 Dec 2015
2014 -360% 01 Jan 2014 31 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.